 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - KalVista Pharmaceuticals Inc. (KALV)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-05 Sale | 2020-02-07 5:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 100 | $17.1 | $1,710 | 82,869 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 5:17 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 100 | $17.11 | $1,711 | 96,634 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 5:14 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 200 | $17.05 | $3,410 | 238,220 (Direct) | View |
| 2019-12-20 Sale | 2019-12-26 5:32 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $17.02 | $45,025 | 82,969 (Direct) | View |
| 2019-12-20 Sale | 2019-12-26 5:30 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 2,300 | $17.02 | $39,150 | 238,420 (Direct) | View |
| 2019-12-12 Sale | 2019-12-16 7:34 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 4,709 | $17.05 | $80,269 | 82,969 (Direct) | View |
| 2019-12-12 Sale | 2019-12-16 7:32 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 7,700 | $17.06 | $131,352 | 240,720 (Direct) | View |
| 2019-09-26 Purchase | 2019-09-30 5:23 pm | KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director | 10,000 | $11.87 | $118,750 | 10,000 (Direct) | View |
| 2019-07-26 Purchase | 2019-07-30 7:37 pm | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 56,367 | $16.99 | $957,737 | 124,566 (Indirect) | View |
| 2019-07-22 Sale | 2019-07-24 5:53 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $18.35 | $134,930 | 82,969 (Direct) | View |
| 2019-07-22 Sale | 2019-07-24 5:52 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 3,300 | $18.62 | $61,443 | 96,734 (Direct) | View |
| 2019-07-17 Purchase | 2019-07-19 6:38 pm | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 61,280 | $17.79 | $1,090,296 | 975,821 (Indirect) | View |
| 2019-07-15 Sale | 2019-07-17 6:52 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $17.04 | $170,407 | 248,510 (Direct) | View |
| 2019-04-22 Sale | 2019-04-23 5:33 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $26.04 | $191,530 | 82,969 (Direct) | View |
| 2019-04-15 Sale | 2019-04-23 5:30 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $24.8 | $247,958 | 258,510 (Direct) | View |
| 2019-04-18 Sale | 2019-04-22 5:58 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 3,073 | $25.7 | $78,976 | 32,500 (Direct) | View |
| 2019-04-17 Sale | 2019-04-18 6:30 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 4,000 | $24.92 | $99,666 | 100,034 (Direct) | View |
| 2019-04-08 Sale | 2019-04-10 7:21 pm | KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner | 50,000 | $29.2 | $1,460,145 | 47,471 (Direct) | View |
| 2019-04-05 Sale | 2019-04-09 5:33 pm | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 5,000 | $30 | $150,011 | 0 (Direct) | View |
| 2019-03-29 Sale | 2019-04-02 6:57 pm | KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner | 97,074 | $28.03 | $2,720,897 | 48,851 (Direct) | View |
| 2019-03-26 Sale | 2019-03-28 5:29 pm | KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner | 124,675 | $28.84 | $3,596,032 | 51,531 (Direct) | View |
| 2019-03-18 Sale | 2019-03-20 4:13 pm | KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner | 262,470 | $26.7 | $7,007,949 | 54,973 (Direct) | View |
| 2019-03-18 Sale | 2019-03-20 4:08 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 500,000 | $28.75 | $14,375,000 | 1,544,112 (Indirect) | View |
| 2019-03-14 Sale | 2019-03-15 8:03 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 3,000 | $30.16 | $90,484 | 268,510 (Direct) | View |
| 2019-03-04 Sale | 2019-03-06 09:05 am | KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner | 75,710 | $22.96 | $1,738,476 | 62,219 (Direct) | View |
| 2019-02-19 Sale | 2019-02-21 2:35 pm | KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner | 214,198 | $20.55 | $4,401,353 | 64,309 (Direct) | View |
| 2019-01-25 Sale | 2019-01-29 6:53 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,453 | $17.06 | $93,015 | 82,969 (Direct) | View |
| 2019-01-22 Sale | 2019-01-24 7:48 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,902 | $17.01 | $32,344 | 82,969 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-12-20 Exercise | 2019-12-26 5:32 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-26 5:32 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 199 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,500 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 3,010 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 199 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,500 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 3,010 | $0.0043 | 82,969 (Direct) | View |
| 2019-10-02 Option Award | 2019-10-03 5:26 pm | N/A 2029-10-01 | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 7,000 | $11.21 | 7,000 (Direct) | View |
| 2019-10-02 Option Award | 2019-10-03 5:25 pm | N/A 2029-10-01 | KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director | 7,000 | $11.21 | 7,000 (Direct) | View |
| 2019-10-02 Option Award | 2019-10-03 5:24 pm | N/A 2029-10-01 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 7,000 | $11.21 | 7,000 (Direct) | View |
| 2019-07-22 Exercise | 2019-07-24 5:53 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0.0043 | 82,969 (Direct) | View |
| 2019-07-22 Exercise | 2019-07-24 5:53 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0.0043 | 82,969 (Direct) | View |
| 2019-06-26 Option Award | 2019-06-28 5:36 pm | N/A 2019-06-25 | KalVista Pharmaceuticals Inc. | KALV | Edwards Martin Director | 14,000 | $20.62 | 14,000 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-17 5:44 pm | N/A 2029-05-14 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 33,750 | $24.23 | 33,750 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-17 5:34 pm | N/A 2029-05-14 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 27,900 | $24.23 | 27,900 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-17 5:29 pm | N/A 2029-05-14 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 9,000 | $24.23 | 9,000 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-17 5:22 pm | N/A 2029-05-14 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 20,250 | $24.23 | 20,250 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-17 5:17 pm | N/A 2029-05-14 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 67,500 | $24.23 | 67,500 (Direct) | View |
| 2019-04-22 Exercise | 2019-04-23 5:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0.0043 | 82,969 (Direct) | View |
| 2019-04-22 Exercise | 2019-04-23 5:33 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0.0043 | 82,969 (Direct) | View |
| 2019-04-22 Option Award | 2019-04-23 5:29 pm | N/A 2029-04-21 | KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director | 14,000 | $26.4 | 14,000 (Direct) | View |
| 2019-04-18 Exercise | 2019-04-22 5:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 1,073 | $6.74 | 32,500 (Direct) | View |
| 2019-04-18 Exercise | 2019-04-22 5:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 2,000 | $8.39 | 32,500 (Direct) | View |
| 2019-04-18 Exercise | 2019-04-22 5:58 pm | N/A 2026-12-28 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 1,073 | $6.74 | 32,500 (Direct) | View |
| 2019-04-18 Exercise | 2019-04-22 5:58 pm | N/A 2026-11-21 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 2,000 | $8.39 | 32,500 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 5:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 5,000 | $7.91 | 0 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 5:33 pm | N/A 2027-03-07 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 5,000 | $7.91 | 0 (Direct) | View |
| 2019-02-01 Option Award | 2019-02-05 5:41 pm | N/A 2029-01-31 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 14,000 | $17.95 | 14,000 (Direct) | View |
| 2019-01-25 Exercise | 2019-01-29 6:53 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,453 | $0.0043 | 82,969 (Direct) | View |
| 2019-01-25 Exercise | 2019-01-29 6:53 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,453 | $0.0043 | 82,969 (Direct) | View |
| 2019-01-22 Exercise | 2019-01-24 7:48 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,302 | $0.0043 | 82,969 (Direct) | View |
| 2019-01-22 Exercise | 2019-01-24 7:48 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 600 | $0.0043 | 82,969 (Direct) | View |
| 2019-01-22 Exercise | 2019-01-24 7:48 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,302 | $0.0043 | 82,969 (Direct) | View |
| 2019-01-22 Exercise | 2019-01-24 7:48 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 600 | $0.0043 | 82,969 (Direct) | View |
| 2016-11-21 Option Award | 2019-01-24 7:44 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 116,810 | $0.0043 | 116,810 (Direct) | View |